UniQure, Syndax, Erasca Drawing Fresh Analyst Interest
Three clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Discover smart ways to save a significant amount each month. Implement these strategies to enhance your financial stability.
13,412 articlesThree clinical-stage biotechs—UniQure, Syndax, and Erasca—are catching analyst attention ahead of key catalysts, with...
Investing in small biotech stocks offers the potential for outsized gains — but only with a clear process. This guide...
When a cybersecurity giant bets $25 billion on a single platform, investors should understand the why, the potential ...
TMC jumped on regulatory news, but the road to deep-seabed mining remains lengthy and costly. This guide breaks down ...
Netflix moves to acquire Ben Affleck's AI startup for up to $600 million, signaling a rapid shift from internal tool-...
Palantir reports strong government revenue growth while warning that adversaries are increasingly targeting AI data c...
Beyond Meat once drew huge hype, but the stock has faced major headwinds. This article breaks down three concrete rea...
Oil prices jump amid Iran tensions, lifting fuel costs for cruise lines. Analysts warn Carnival could bear a sizable ...
Investors are weighing if broadcom stock going $460? is a plausible milestone. This guide breaks down the drivers, ri...
Cruise investors wrestle with Carnival earnings anxiety: good, the push-pull between sunny passenger demand and risin...
Tesla unveils Terafab, a new in-house semiconductor fabrication unit focused on robotics and AI chips. Early signals ...
A new $150 million startup thinks real world connection can counter online detachment. This report examines the plan,...